Meaning
Value provided to a corporation in exchange for equity shares or assets forms the foundation of valid issuance under statutory equity guidelines. Under statutory mandates, corporate consideration consists of tangible benefits, cash, performed services, or binding promises received by an enterprise when issuing stock. The requirement ensures that an entity receives real economic value before granting equity ownership rights to participants.
Beyond equity issuance, the concept bounds corporate transactions where directors must confirm that fair exchange occurs without depleting corporate value.
Statutory Valuation
Equity legislation dictates acceptable categories of value that support share issuances across jurisdictions. Historical practice restricted corporate consideration to physical property or past labor, excluding future services and promissory notes. Modern corporate codes expand these boundaries to permit any tangible or intangible benefit to the enterprise, including contractual commitments for future work or debt cancellation.
Directors evaluate these assets at the time of board approval, establishing a monetary value that binds the company. When valuation decisions occur in good faith, statutory standards protect board determinations from collateral challenge by external claimants.
Board Discretion
Directors hold primary responsibility for assessing whether incoming payment meets standard legal requirements. Board members determine the adequacy of corporate consideration through formal resolutions during equity grants, establishing clear records of corporate exchange.
Capital Adequacy
Insufficient asset exchange exposes equity holders to liabilities regarding par value shortfalls. Recipients of stock issued without adequate corporate consideration face potential claims from corporate creditors during liquidation scenarios. These obligations compel equity recipients to make up the shortfall up to the par value of shares.
Proper documentation of valuation protects founders and incoming investors against future claims of stock invalidity.